Steven Cohen's CC Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 116,431 shares of The Chemours Company (CC) worth $1.37 M, representing 0.00% of the portfolio. First purchased in 2016-Q3, this long-term strategic position has been held for 28 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in CC, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2018, adding 989,926 shares. Largest reduction occurred in Q2 2018, reducing 1.57 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's The Chemours Company (CC) Holding Value Over Time
Track share changes against reported price movement
Quarterly The Chemours Company (CC) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -902,105 | Reduce 88.57% | 116,431 | $11.79 |
| Q3 2025 | +686,874 | Add 207.10% | 1.02 M | $15.84 |
| Q2 2025 | +331,662 | New Buy | 331,662 | $11.45 |
| Q1 2025 | -334,070 | Sold Out | 0 | $0.00 |
| Q4 2024 | +334,070 | New Buy | 334,070 | $16.90 |
| Q3 2024 | -27,046 | Sold Out | 0 | $0.00 |
| Q2 2024 | -419,046 | Reduce 93.94% | 27,046 | $22.57 |
| Q1 2024 | +131,792 | Add 41.93% | 446,092 | $26.26 |
| Q4 2023 | +314,300 | New Buy | 314,300 | $31.54 |
| Q4 2021 | -17,500 | Sold Out | 0 | $0.00 |
| Q3 2021 | +17,500 | New Buy | 17,500 | $29.09 |
| Q3 2020 | -708,299 | Sold Out | 0 | $0.00 |
| Q2 2020 | +614,999 | Add 659.16% | 708,299 | $15.35 |
| Q1 2020 | +93,300 | New Buy | 93,300 | $8.87 |
| Q4 2019 | -357,937 | Sold Out | 0 | $0.00 |
| Q3 2019 | +230,937 | Add 181.84% | 357,937 | $14.94 |
| Q2 2019 | -214,911 | Reduce 62.86% | 127,000 | $24.00 |
| Q1 2019 | +341,911 | New Buy | 341,911 | $37.16 |
| Q4 2018 | -219,971 | Sold Out | 0 | $0.00 |
| Q3 2018 | +160,471 | Add 269.70% | 219,971 | $39.44 |
| Q2 2018 | -1.57 M | Reduce 96.36% | 59,500 | $44.35 |
| Q1 2018 | +989,926 | Add 153.73% | 1.63 M | $48.71 |
| Q4 2017 | +578,258 | Add 880.15% | 643,958 | $50.06 |
| Q3 2017 | +65,700 | New Buy | 65,700 | $50.61 |
| Q2 2017 | -831,405 | Sold Out | 0 | $0.00 |
| Q1 2017 | +831,405 | New Buy | 831,405 | $38.50 |
| Q4 2016 | -264,000 | Sold Out | 0 | $0.00 |
| Q3 2016 | +264,000 | New Buy | 264,000 | $16.00 |
Steven Cohen's The Chemours Company Investment FAQs
Steven Cohen first purchased The Chemours Company (CC) in Q3 2016, acquiring 264,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held The Chemours Company (CC) for 28 quarters since Q3 2016.
Steven Cohen's largest addition to The Chemours Company (CC) was in Q1 2018, adding 1,633,884 shares worth $79.59 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 116,431 shares of The Chemours Company (CC), valued at approximately $1.37 M.
As of the Q4 2025 filing, The Chemours Company (CC) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in The Chemours Company (CC) was 1,633,884 shares, as reported at the end of Q1 2018.